Top Tweets for #darpins
With the 43rd Annual J.P. Morgan Healthcare Conference behind us, we wanted to share highlights of our week.
👉https://t.co/uA2syIc7hK
#radiopharmaceuticals #immunooncology #DARPins #cancerresearch #investing
We’re at the 43rd Annual JP Morgan Healthcare Conference! CEO Patrick Amstutz is presenting January 15 at 9:00am PT (6:00pm CET).
👉 https://t.co/wQLzcpQKyc
#radiopharmaceuticals #immunooncology #DARPins #cancerresearch #investing
The crystal structure of a cryo-EM imaging scaffold with rigid DARPin fusions shows that these scaffolds may act as crystallization chaperones, thus extending their utility for structural studies @ucla @IUCr #DARPins #ProteinCages #ProteinDesign https://t.co/TY2aQe8DAm
Matthew P. Agdanowski et al.: X-ray crystal structure of a designed rigidified imaging scaffold in the ligand-free conformation #DARPins #ProteinCages #ProteinDesign @ucla... #IUCr https://t.co/10PGgvTbyN
May is #NationalCancerResearchMonth. By harnessing the unique advantages of #DARPins, we are developing novel treatments for people with cancer, including MP0533, a novel tetra-specific #DARPin therapy in clinical development for patients with AML.
#NCRM24
Today at #Immuno2024, MP Sr. Scientist Natalia Venetz will present on #DARPins as a novel therapeutic modality, discussing conditionally activated DARPin therapeutics for #immunooncology, MP0533 and Switch-DARPin.
More: https://t.co/lhJQhOyois
@OGConferences
Last week our MP colleagues gathered for our Spring Social to debrief the Spring Portfolio Review and celebrate our hard work to expand #DARPins’ potential to help patients through innovative approaches.
#SwissBiotech #oncology #DARPin #RadioDARPins
NEW #JPM24 TIMESLOT: Our CEO Patrick Amstutz will be presenting on Wednesday, Jan 10th at 10:30 am PT (1:30 pm ET/7:30 pm CET).
More: https://t.co/ixDw2q8h3A
#DARPins #RadioDARPins #radiopharma #oncology #hematology #bloodcancer #AcuteMyeloidLeukemia #cancer #immunooncology
We’re looking forward to #JPM24, where our CEO Patrick Amstutz will be presenting. MP leadership will also be at the #BaaderHelvea Swiss Equities Conference & the Octavian Seminar for presentations & meetings with the Swiss investment community. https://t.co/JSrnGkiGDV
#DARPins
We had a great time presenting initial positive results from MP0533 at #ASH23 this year and connecting with so many dedicated researchers who are as committed as we are to transforming the lives of patients.
#cancer
#bloodcancer
#AML
#hematology
#immunooncology
#DARPins
We are excited to attend @UBS Swiss Equity Technology and Innovation Days and @Jefferies London Healthcare Conference this week to discuss our latest progress and opportunities for further innovation.
#DARPins
#RadioDARPins
#immunooncology
#cancer
#radioligands
#radiopharma
🚨 paper alarm 😃 Congratulations to the @goetheuni team led by Volker Doetsch, Stefan Knapp @thesgcfrankfurt , Plückthun @uzh_en, assisted by Mathias Rosenfeldt @Uni_WUE @diefenbacherl on their work on #DARPins https://t.co/Hc9e8jzW5N
Tomorrow is #ClinicalTrialsDay, and we want to thank our team members, partners, and patients who participate in #clinicaltrials so innovative medicines can reach more people in need.
Learn more: https://t.co/0ZRvGVOG5v
#ICTD23 #cancerresearch #DARPins #MP0317 #MP0533 #AML
Yesterday marked the start of #NationalCancerResearchMonth. We’re working to develop novel treatments for cancer by harnessing #DARPins unique advantages. Our #MP0317 therapeutic candidate is the perfect example of that. Learn more about how #MP0317 works in this video:
#NCRM23
At Molecular Partners, we leverage the many intrinsic advantages of #DARPins therapeutics.
Every dose received contains more molecules per gram than a larger molecule like an antibody, which provides a range of advantages including better tumor penetration.
We are searching for individuals ready to contribute to our mission to deliver #DARPins as a new class of medicines to patients across the globe.
Learn more about our collaborative and passionate working environment: https://t.co/bABXhJwflC
#BiotechJobs
This was a year full innovation and progress. We are proud of the steps we took towards delivering #DARPins as a new class of medicines for patients living with complex diseases around the world.
We look forward to all that 2023 will bring!
#DARPins can block multiple targets at once, making it difficult for a single mutation in a virus or cancer cell to break through. This could give our candidates broader efficacy and allow them to remain powerful against evolving targets.
Learn more:
https://t.co/FVMQTq19Q9
One key advantage to our DARPin® biology approach is that #DARPins are smaller in size than other types of medicines, allowing for greater tissue penetration across a wide variety of applications.
Learn more: https://t.co/xM7qnUFARx #DARPin #Biotechnology
Last Seen Hashtags on Sotwe
acnoctem
Seen from Turkey
adanagay
Seen from Turkey
مداعبه
Seen from Lebanon
hot tango
Seen from Germany
CaughtOnCamera
Seen from Turkey
aunty big boobs
Seen from India
minichatt filter:videos()**
Seen from Turkey
ควยพม่า
Seen from Thailand
ometv colmek
Seen from Japan
NationalDonutDay
Seen from Turkey
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers